Recently, we published a study with @P53Mdm2 using our ICSBCS Ghanaian organoids led by Florencia Madorsky of the @ElementoLab@WCMEnglanderIPM@MLauritamartin
Check it out at Cancer Letters!
https://t.co/VOQcJl0d1Q
Are any other moms out there mad at the lyrics of Wheels on the Bus? The mommies on the bus go “shh” and the daddies on the bus go “I love you”!? REALLY!?!? Each time that song comes on my twin’s bus…😡 @Momademia
Great first day for the 3D Cell Culture Summit @WCMEnglanderIPM, hosted by @CorningLifeSci, and featuring a presentation, "Next Generation Patient Derived Tumor Organoids," by our colleague Dr. Enrique Podaza (@epodaza)!
#organoids#PrecisionMedicine
Don't miss the next @WCMEnglanderIPM Seminar Series lecture, "Quantitative Mechanical Characterization of in Vitro Tumor Models," presented by Dr. Kazunori Hoshino, Assoc. Prof., Dept. of Biomedical Engineering @UConn
Tomorrow at noon, zoom mtg. info. emailed to #WCM staff.
We're hiring!
We have a number of exciting new career opportunities, including a two-year Research Clinical Fellowship in #PrecisionMedicine and a Laboratory Administrative Assistant.
Thank you for applying and circulating within your networks.
https://t.co/IYh5Uk3pTb
Two-year Research Clinical Fellowship in Precision Medicine. Oncologists and medical trainees will be considered. Prior experience in molecular biology/molecular pathology is encouraged. - https://t.co/zUWRr3obpp
We are pleased to introduce our colleague Jenna Moyer, a Research Specialist on the @WCMEnglanderIPM#organoid team, and hope you enjoy learning about her background, research interests, what keeps her motivated, outside interests, and more!
https://t.co/ULfgbmuncX
Advanced Materials: We report synthetic hydrogel-based #prostate cancer #organoids that enabled discovery of Dopamine Receptor D2 inhibitors as potential new therapy for epigenetically reprogrammed neuroendocrine prostate #cancer. Congrats @MosqueraPhD👏🏽! https://t.co/T7hMazTiou
Join us, we're hiring!
We seek a dynamic individual who will be responsible for designing and executing in situ validation assays (FISH, RNAish) in the context of Precision Oncology studies focused on defining novel molecular alterations in cancer.
https://t.co/IYh5Uk3pTb